Sumitomo Pharma Co., Ltd. (DNPUF)

Market Cap	3.73B
Revenue (ttm)	2.88B
Net Income (ttm)	131.02M
Shares Out	n/a
EPS (ttm)	0.33
PE Ratio	28.49
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	400
Average Volume	453
Open	8.97
Previous Close	n/a
Day's Range	8.97 - 8.97
52-Week Range	3.44 - 8.97
Beta	0.54
RSI	79.96
Earnings Date	Jul 31, 2025

About Sumitomo Pharma

Sumitomo Pharma Co., Ltd. engages in manufacture, and purchase and sale of pharmaceutical products for medical treatment in Japan, North America, and Asia. The company offers therapeutic agents for parkinson’s disease, type 2 diabetes, advanced prostate cancer, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. It also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. Further, the company offers veterinary drugs, medical devices, etc. It ha...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1897
• Employees: 3,832
• Stock Exchange: OTCMKTS
• Ticker Symbol: DNPUF

Financial Performance

Financial numbers in JPY